BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Rybak LP, Ramkumar V. Ototoxicity. Kidney Int. 2007;72:931-935. [PMID: 17653135 DOI: 10.1038/sj.ki.5002434] [Cited by in Crossref: 183] [Cited by in F6Publishing: 157] [Article Influence: 13.1] [Reference Citation Analysis]
Number Citing Articles
1 Leitner MG, Halaszovich CR, Oliver D. Aminoglycosides Inhibit KCNQ4 Channels in Cochlear Outer Hair Cells via Depletion of Phosphatidylinositol(4,5)bisphosphate. Mol Pharmacol 2010;79:51-60. [DOI: 10.1124/mol.110.068130] [Cited by in Crossref: 36] [Cited by in F6Publishing: 24] [Article Influence: 3.3] [Reference Citation Analysis]
2 Francis SP, Kramarenko II, Brandon CS, Lee FS, Baker TG, Cunningham LL. Celastrol inhibits aminoglycoside-induced ototoxicity via heat shock protein 32. Cell Death Dis 2011;2:e195. [PMID: 21866174 DOI: 10.1038/cddis.2011.76] [Cited by in Crossref: 37] [Cited by in F6Publishing: 33] [Article Influence: 3.7] [Reference Citation Analysis]
3 Zhuang Y, Li L, Feng L, Wang S, Su H, Liu H, Liu H, Wu Y. Mitochondrion-targeted selenium nanoparticles enhance reactive oxygen species-mediated cell death. Nanoscale 2020;12:1389-96. [PMID: 31913383 DOI: 10.1039/c9nr09039h] [Cited by in Crossref: 7] [Article Influence: 7.0] [Reference Citation Analysis]
4 Yang TH, Young YH, Liu SH. EGb 761 (Ginkgo biloba) protects cochlear hair cells against ototoxicity induced by gentamicin via reducing reactive oxygen species and nitric oxide-related apoptosis. The Journal of Nutritional Biochemistry 2011;22:886-94. [DOI: 10.1016/j.jnutbio.2010.08.009] [Cited by in Crossref: 38] [Cited by in F6Publishing: 32] [Article Influence: 3.8] [Reference Citation Analysis]
5 Jensen-Smith HC, Hallworth R, Nichols MG. Gentamicin rapidly inhibits mitochondrial metabolism in high-frequency cochlear outer hair cells. PLoS One 2012;7:e38471. [PMID: 22715386 DOI: 10.1371/journal.pone.0038471] [Cited by in Crossref: 36] [Cited by in F6Publishing: 36] [Article Influence: 4.0] [Reference Citation Analysis]
6 Hampel P, Römermann K, MacAulay N, Löscher W. Azosemide is more potent than bumetanide and various other loop diuretics to inhibit the sodium-potassium-chloride-cotransporter human variants hNKCC1A and hNKCC1B. Sci Rep 2018;8:9877. [PMID: 29959396 DOI: 10.1038/s41598-018-27995-w] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 4.0] [Reference Citation Analysis]
7 van Kleef RG, Vijverberg HP, Westerink RH. Selective inhibition of human heteromeric alpha9alpha10 nicotinic acetylcholine receptors at a low agonist concentration by low concentrations of ototoxic organic solvents. Toxicol In Vitro 2008;22:1568-72. [PMID: 18602458 DOI: 10.1016/j.tiv.2008.06.007] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.6] [Reference Citation Analysis]
8 Arnold A, Brouse SD, Pitcher WD, Hall RG 2nd. Empiric therapy for gram-negative pathogens in nosocomial and health care-associated pneumonia: starting with the end in mind. J Intensive Care Med 2010;25:259-70. [PMID: 20622257 DOI: 10.1177/0885066610371189] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 1.1] [Reference Citation Analysis]
9 Galsky MD, Hahn NM, Rosenberg J, Sonpavde G, Hutson T, Oh WK, Dreicer R, Vogelzang N, Sternberg CN, Bajorin DF, Bellmunt J. Treatment of patients with metastatic urothelial cancer "unfit" for Cisplatin-based chemotherapy. J Clin Oncol 2011;29:2432-8. [PMID: 21555688 DOI: 10.1200/JCO.2011.34.8433] [Cited by in Crossref: 296] [Cited by in F6Publishing: 100] [Article Influence: 29.6] [Reference Citation Analysis]
10 Fosso MY, Li Y, Garneau-Tsodikova S. New trends in aminoglycosides use. Medchemcomm 2014;5:1075-91. [PMID: 25071928 DOI: 10.1039/C4MD00163J] [Cited by in Crossref: 54] [Cited by in F6Publishing: 28] [Article Influence: 7.7] [Reference Citation Analysis]
11 Wrześniok D, Rok J, Beberok A, Rzepka Z, Respondek M, Pilawa B, Zdybel M, Delijewski M, Buszman E. Kanamycin induces free radicals formation in melanocytes: An important factor for aminoglycosides ototoxicity. J Cell Biochem 2018. [PMID: 30461043 DOI: 10.1002/jcb.26817] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
12 Ding D, Prolla T, Someya S, Manohar S, Salvi R. Roles of Bak and Sirt3 in Paraquat-Induced Cochlear Hair Cell Damage. Neurotox Res 2021;39:1227-37. [PMID: 33900547 DOI: 10.1007/s12640-021-00366-6] [Reference Citation Analysis]
13 Wang Y, Wang J, Hao H, Cai M, Wang S, Ma J, Li Y, Mao C, Zhang S. In Vitro and in Vivo Mechanism of Bone Tumor Inhibition by Selenium-Doped Bone Mineral Nanoparticles. ACS Nano 2016;10:9927-37. [PMID: 27797178 DOI: 10.1021/acsnano.6b03835] [Cited by in Crossref: 95] [Cited by in F6Publishing: 72] [Article Influence: 19.0] [Reference Citation Analysis]
14 Cannizzaro E, Cannizzaro C, Plescia F, Martines F, Soleo L, Pira E, Lo Coco D. Exposure to ototoxic agents and hearing loss: A review of current knowledge. Hearing, Balance and Communication 2014;12:166-75. [DOI: 10.3109/21695717.2014.964939] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
15 Curhan G, Curhan S. Epidemiology of Hearing Impairment. In: Popelka GR, Moore BCJ, Fay RR, Popper AN, editors. Hearing Aids. Cham: Springer International Publishing; 2016. pp. 21-58. [DOI: 10.1007/978-3-319-33036-5_2] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.6] [Reference Citation Analysis]
16 Poulikakos P, Falagas ME. Aminoglycoside therapy in infectious diseases. Expert Opinion on Pharmacotherapy 2013;14:1585-97. [DOI: 10.1517/14656566.2013.806486] [Cited by in Crossref: 46] [Cited by in F6Publishing: 39] [Article Influence: 5.8] [Reference Citation Analysis]
17 Humphrey C, Veve MP, Walker B, Shorman MA. Long-term vancomycin use had low risk of ototoxicity. PLoS One 2019;14:e0224561. [PMID: 31693679 DOI: 10.1371/journal.pone.0224561] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
18 Auerbach BD, Rodrigues PV, Salvi RJ. Central gain control in tinnitus and hyperacusis. Front Neurol 2014;5:206. [PMID: 25386157 DOI: 10.3389/fneur.2014.00206] [Cited by in Crossref: 147] [Cited by in F6Publishing: 131] [Article Influence: 21.0] [Reference Citation Analysis]
19 Ciarimboli G. Membrane transporters as mediators of Cisplatin effects and side effects. Scientifica (Cairo). 2012;2012:473829. [PMID: 24278698 DOI: 10.6064/2012/473829] [Cited by in Crossref: 28] [Cited by in F6Publishing: 26] [Article Influence: 3.1] [Reference Citation Analysis]
20 Patel M, Cai Q, Ding D, Salvi R, Hu Z, Hu BH. The miR-183/Taok1 target pair is implicated in cochlear responses to acoustic trauma. PLoS One 2013;8:e58471. [PMID: 23472202 DOI: 10.1371/journal.pone.0058471] [Cited by in Crossref: 24] [Cited by in F6Publishing: 26] [Article Influence: 3.0] [Reference Citation Analysis]
21 Chen LF, Kaye D. Current use for old antibacterial agents: polymyxins, rifamycins, and aminoglycosides. Infect Dis Clin North Am 2009;23:1053-75, x. [PMID: 19909897 DOI: 10.1016/j.idc.2009.06.004] [Cited by in Crossref: 40] [Cited by in F6Publishing: 33] [Article Influence: 3.6] [Reference Citation Analysis]
22 Kim HJ, Lee JO, Koo JW, Kim JS, Ban J. Gentamicin-induced bilateral vestibulopathy in rabbits: vestibular dysfunction and histopathology. Laryngoscope 2013;123:E51-8. [PMID: 23619994 DOI: 10.1002/lary.24106] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
23 Pietola L. Effects of p27 Kip1 - and p53- shRNAs on kanamycin damaged mouse cochlea. WJO 2012;2:1. [DOI: 10.5319/wjo.v2.i1.1] [Reference Citation Analysis]
24 Dobrzyńska I, Skrzydlewska E, Figaszewski ZA. Effects of novel dinuclear cisplatinum(II) complexes on the electric properties of human breast cancer cells. J Membr Biol 2014;247:167-73. [PMID: 24343572 DOI: 10.1007/s00232-013-9620-1] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
25 Kopecky BJ, Decook R, Fritzsch B. N-Myc and L-Myc are essential for hair cell formation but not maintenance. Brain Res 2012;1484:1-14. [PMID: 23022312 DOI: 10.1016/j.brainres.2012.09.027] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 1.3] [Reference Citation Analysis]
26 Yao M, Zhang J, Li Z, Bai X, Ma J, Li Y. Liraglutide Protects Nucleus Pulposus Cells Against High-Glucose Induced Apoptosis by Activating PI3K/Akt/ mTOR/Caspase-3 and PI3K/Akt/GSK3β/Caspase-3 Signaling Pathways. Front Med (Lausanne) 2021;8:630962. [PMID: 33681258 DOI: 10.3389/fmed.2021.630962] [Reference Citation Analysis]
27 Zhao P, Li M, Chen Y, He C, Zhang X, Fan T, Yang T, Lu Y, Lee RJ, Ma X, Luo J, Xiang G. Selenium-doped calcium carbonate nanoparticles loaded with cisplatin enhance efficiency and reduce side effects. Int J Pharm 2019;570:118638. [PMID: 31449842 DOI: 10.1016/j.ijpharm.2019.118638] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 3.5] [Reference Citation Analysis]
28 Chen LF, Kaye D. Current Use for Old Antibacterial Agents: Polymyxins, Rifamycins, and Aminoglycosides. Medical Clinics of North America 2011;95:819-42. [DOI: 10.1016/j.mcna.2011.03.007] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 1.3] [Reference Citation Analysis]
29 Böttger EC, Schacht J. The mitochondrion: a perpetrator of acquired hearing loss. Hear Res 2013;303:12-9. [PMID: 23361190 DOI: 10.1016/j.heares.2013.01.006] [Cited by in Crossref: 109] [Cited by in F6Publishing: 84] [Article Influence: 13.6] [Reference Citation Analysis]
30 Santos NAGD, Ferreira RS, Santos ACD. Overview of cisplatin-induced neurotoxicity and ototoxicity, and the protective agents. Food Chem Toxicol 2020;136:111079. [PMID: 31891754 DOI: 10.1016/j.fct.2019.111079] [Cited by in Crossref: 19] [Cited by in F6Publishing: 13] [Article Influence: 9.5] [Reference Citation Analysis]
31 Someya S, Kim MJ. Cochlear detoxification: Role of alpha class glutathione transferases in protection against oxidative lipid damage, ototoxicity, and cochlear aging. Hear Res 2021;402:108002. [PMID: 32600853 DOI: 10.1016/j.heares.2020.108002] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
32 Crabb SJ, Martin K, Abab J, Ratcliffe I, Thornton R, Lineton B, Ellis M, Moody R, Stanton L, Galanopoulou A, Maishman T, Geldart T, Bayne M, Davies J, Lamb C, Popat S, Joffe JK, Nutting C, Chester J, Hartley A, Thomas G, Ottensmeier C, Huddart R, King E. COAST (Cisplatin ototoxicity attenuated by aspirin trial): A phase II double-blind, randomised controlled trial to establish if aspirin reduces cisplatin induced hearing-loss. Eur J Cancer 2017;87:75-83. [PMID: 29128692 DOI: 10.1016/j.ejca.2017.09.033] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 3.0] [Reference Citation Analysis]
33 Salehi N, Akbari M, Pourbakht A, Haghani H, Janahmadi M. A Dose-Effect Study of Cisplatin Ototoxicity in Albino Guinea Pigs. Iran J Otorhinolaryngol 2020;32:155-61. [PMID: 32596174 DOI: 10.22038/ijorl.2019.41914.2368] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
34 Mukherjea D, Jajoo S, Whitworth C, Bunch JR, Turner JG, Rybak LP, Ramkumar V. Short interfering RNA against transient receptor potential vanilloid 1 attenuates cisplatin-induced hearing loss in the rat. J Neurosci. 2008;28:13056-13065. [PMID: 19052196 DOI: 10.1523/jneurosci.1307-08.2008] [Cited by in Crossref: 83] [Cited by in F6Publishing: 49] [Article Influence: 6.9] [Reference Citation Analysis]
35 Fan GR, Yin ZD, Sun Y, Chen S, Zhang WJ, Huang X, Kong WJ, Zhang HL. Reversible neurotoxicity of kanamycin on dorsal cochlear nucleus. Brain Res 2013;1502:30-46. [PMID: 23333799 DOI: 10.1016/j.brainres.2012.12.049] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
36 Han M, Yu D, Song Q, Wang J, Dong P, He J. Polybrene: Observations on cochlear hair cell necrosis and minimal lentiviral transduction of cochlear hair cells. Neurosci Lett 2015;600:164-70. [PMID: 26071903 DOI: 10.1016/j.neulet.2015.06.011] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
37 Lin SCY, Thorne PR, Housley GD, Vlajkovic SM. Resistance to neomycin ototoxicity in the extreme basal (hook) region of the mouse cochlea. Histochem Cell Biol 2018;150:281-9. [PMID: 29862415 DOI: 10.1007/s00418-018-1683-8] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
38 Liu X, Li M, Smyth H, Zhang F. Otic drug delivery systems: formulation principles and recent developments. Drug Dev Ind Pharm 2018;44:1395-408. [PMID: 29659300 DOI: 10.1080/03639045.2018.1464022] [Cited by in Crossref: 9] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
39 Scobioala S, Parfitt R, Matulat P, Kittel C, Ebrahimi F, Wolters H, Am Zehnhoff-Dinnesen A, Eich HT. Impact of radiation technique, radiation fraction dose, and total cisplatin dose on hearing : Retrospective analysis of 29 medulloblastoma patients. Strahlenther Onkol 2017;193:910-20. [PMID: 28887665 DOI: 10.1007/s00066-017-1205-y] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 2.5] [Reference Citation Analysis]
40 Debacker JR, Harrison RT, Bielefeld EC. Cisplatin-induced threshold shift in the CBA/CaJ, C57BL/6J, BALB/cJ mouse models of hearing loss. Hearing Research 2020;387:107878. [DOI: 10.1016/j.heares.2019.107878] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 8.0] [Reference Citation Analysis]
41 Herrera-Pérez Z, Gretz N, Dweep H. A Comprehensive Review on the Genetic Regulation of Cisplatin-induced Nephrotoxicity. Curr Genomics 2016;17:279-93. [PMID: 27252593 DOI: 10.2174/1389202917666160202220555] [Cited by in Crossref: 17] [Cited by in F6Publishing: 13] [Article Influence: 3.4] [Reference Citation Analysis]
42 Wood JW, Bas E, Gupta C, Selman Y, Eshraghi A, Telischi FF, Van De Water TR. Otoprotective Properties of Mannitol Against Gentamicin Induced Hair Cell Loss. Otology & Neurotology 2014;35:e187-94. [DOI: 10.1097/mao.0000000000000342] [Cited by in Crossref: 15] [Cited by in F6Publishing: 9] [Article Influence: 2.1] [Reference Citation Analysis]
43 Tian CJ, Kim SW, Kim YJ, Lim HJ, Park R, So HS, Choung YH. Red ginseng protects against gentamicin-induced balance dysfunction and hearing loss in rats through antiapoptotic functions of ginsenoside Rb1. Food Chem Toxicol 2013;60:369-76. [PMID: 23933362 DOI: 10.1016/j.fct.2013.07.069] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.9] [Reference Citation Analysis]
44 Uzun L, Balbaloglu E, Akinci H. Garlic-Supplemented Diet Attenuates Gentamicin-Induced Ototoxicity: An Experimental Study. Ann Otol Rhinol Laryngol 2012;121:139-43. [DOI: 10.1177/000348941212100211] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
45 Debacker JR, Harrison RT, Bielefeld EC. Long-Term Synergistic Interaction of Cisplatin- and Noise-Induced Hearing Losses: . Ear and Hearing 2017;38:282-91. [DOI: 10.1097/aud.0000000000000391] [Cited by in Crossref: 9] [Cited by in F6Publishing: 2] [Article Influence: 2.3] [Reference Citation Analysis]
46 Grewal S, Merchant T, Reymond R, McInerney M, Hodge C, Shearer P. Auditory late effects of childhood cancer therapy: a report from the Children's Oncology Group. Pediatrics 2010;125:e938-50. [PMID: 20194279 DOI: 10.1542/peds.2009-1597] [Cited by in Crossref: 125] [Cited by in F6Publishing: 86] [Article Influence: 11.4] [Reference Citation Analysis]
47 Prasad KN, Bondy SC. Increased oxidative stress, inflammation, and glutamate: Potential preventive and therapeutic targets for hearing disorders. Mech Ageing Dev 2020;185:111191. [PMID: 31765645 DOI: 10.1016/j.mad.2019.111191] [Cited by in Crossref: 16] [Cited by in F6Publishing: 11] [Article Influence: 8.0] [Reference Citation Analysis]
48 Langer T, am Zehnhoff-dinnesen A, Radtke S, Meitert J, Zolk O. Understanding platinum-induced ototoxicity. Trends in Pharmacological Sciences 2013;34:458-69. [DOI: 10.1016/j.tips.2013.05.006] [Cited by in Crossref: 122] [Cited by in F6Publishing: 89] [Article Influence: 15.3] [Reference Citation Analysis]
49 Lin SCY, Thorne PR, Housley GD, Vlajkovic SM. Purinergic Signaling and Aminoglycoside Ototoxicity: The Opposing Roles of P1 (Adenosine) and P2 (ATP) Receptors on Cochlear Hair Cell Survival. Front Cell Neurosci 2019;13:207. [PMID: 31156393 DOI: 10.3389/fncel.2019.00207] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
50 Racano A, Pazionis T, Farrokhyar F, Deheshi B, Ghert M. High infection rate outcomes in long-bone tumor surgery with endoprosthetic reconstruction in adults: a systematic review. Clin Orthop Relat Res. 2013;471:2017-2027. [PMID: 23404421 DOI: 10.1007/s11999-013-2842-9] [Cited by in Crossref: 61] [Cited by in F6Publishing: 36] [Article Influence: 7.6] [Reference Citation Analysis]
51 Neveux S, Smith NK, Roche A, Blough BE, Pathmasiri W, Coffin AB. Natural Compounds as Occult Ototoxins? Ginkgo biloba Flavonoids Moderately Damage Lateral Line Hair Cells. J Assoc Res Otolaryngol 2017;18:275-89. [PMID: 27896487 DOI: 10.1007/s10162-016-0604-6] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 2.4] [Reference Citation Analysis]
52 Lykke K, Töllner K, Feit PW, Erker T, MacAulay N, Löscher W. The search for NKCC1-selective drugs for the treatment of epilepsy: Structure-function relationship of bumetanide and various bumetanide derivatives in inhibiting the human cation-chloride cotransporter NKCC1A. Epilepsy Behav 2016;59:42-9. [PMID: 27088517 DOI: 10.1016/j.yebeh.2016.03.021] [Cited by in Crossref: 22] [Cited by in F6Publishing: 20] [Article Influence: 4.4] [Reference Citation Analysis]
53 Robinson AM, Vujanovic I, Richter CP. Minocycline protection of neomycin induced hearing loss in gerbils. Biomed Res Int 2015;2015:934158. [PMID: 25950003 DOI: 10.1155/2015/934158] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
54 Martín-Saldaña S, Palao-Suay R, Aguilar MR, García-Fernández L, Arévalo H, Trinidad A, Ramírez-Camacho R, San Román J. pH-sensitive polymeric nanoparticles with antioxidant and anti-inflammatory properties against cisplatin-induced hearing loss. J Control Release 2018;270:53-64. [PMID: 29197586 DOI: 10.1016/j.jconrel.2017.11.032] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 4.5] [Reference Citation Analysis]
55 Hahn H, Salt AN, Schumacher U, Plontke SK. Gentamicin concentration gradients in scala tympani perilymph following systemic applications. Audiol Neurootol 2013;18:383-91. [PMID: 24192668 DOI: 10.1159/000355283] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 1.6] [Reference Citation Analysis]
56 Bas E, Van De Water TR, Gupta C, Dinh J, Vu L, Martínez-Soriano F, Láinez JM, Marco J. Efficacy of three drugs for protecting against gentamicin-induced hair cell and hearing losses. Br J Pharmacol 2012;166:1888-904. [PMID: 22320124 DOI: 10.1111/j.1476-5381.2012.01890.x] [Cited by in Crossref: 32] [Cited by in F6Publishing: 28] [Article Influence: 3.6] [Reference Citation Analysis]
57 Lin C, Oshima T, Oda K, Yamauchi D, Tsai M, Kobayashi T. Ototoxic interaction of kanamycin and 3-nitropropionic acid. Acta Oto-Laryngologica 2009;128:1280-5. [DOI: 10.1080/00016480801935541] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
58 Ojano-dirain CP, Antonelli PJ, Le Prell CG. Mitochondria-Targeted Antioxidant MitoQ Reduces Gentamicin-Induced Ototoxicity. Otology & Neurotology 2014;35:533-9. [DOI: 10.1097/mao.0000000000000192] [Cited by in Crossref: 28] [Cited by in F6Publishing: 14] [Article Influence: 4.0] [Reference Citation Analysis]
59 Brito R, Sheth S, Mukherjea D, Rybak LP, Ramkumar V. TRPV1: A Potential Drug Target for Treating Various Diseases. Cells 2014;3:517-45. [PMID: 24861977 DOI: 10.3390/cells3020517] [Cited by in Crossref: 69] [Cited by in F6Publishing: 58] [Article Influence: 9.9] [Reference Citation Analysis]
60 Kim Y, Kim M, Cho H, Oh S, Lee I, Kim U, Lee K. Galangin prevents aminoglycoside-induced ototoxicity by decreasing mitochondrial production of reactive oxygen species in mouse cochlear cultures. Toxicology Letters 2016;245:78-85. [DOI: 10.1016/j.toxlet.2016.01.005] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 3.0] [Reference Citation Analysis]
61 Kim HJ, Lee JO, Kim JS. Protective Effects of Deferoxamine on Vestibulotoxicity in Gentamicin-Induced Bilateral Vestibulopathy Rat Model. Front Neurol 2021;12:650752. [PMID: 33841317 DOI: 10.3389/fneur.2021.650752] [Reference Citation Analysis]
62 Kaur T, Mukherjea D, Sheehan K, Jajoo S, Rybak LP, Ramkumar V. Short interfering RNA against STAT1 attenuates cisplatin-induced ototoxicity in the rat by suppressing inflammation. Cell Death Dis. 2011;2:e180. [PMID: 21776018 DOI: 10.1038/cddis.2011.63] [Cited by in Crossref: 89] [Cited by in F6Publishing: 80] [Article Influence: 8.9] [Reference Citation Analysis]
63 Cascão R, Fonseca JE, Moita LF. Celastrol: A Spectrum of Treatment Opportunities in Chronic Diseases. Front Med (Lausanne) 2017;4:69. [PMID: 28664158 DOI: 10.3389/fmed.2017.00069] [Cited by in Crossref: 99] [Cited by in F6Publishing: 75] [Article Influence: 24.8] [Reference Citation Analysis]
64 Dogan M, Polat H, Yasar M, Bayram A, Karatas D, Hira İ, Kale A, Senel F, Özcan İ. Protective role of misoprostol in prevention of gentamicin ototoxicity. Int J Pediatr Otorhinolaryngol 2017;96:140-4. [PMID: 28390604 DOI: 10.1016/j.ijporl.2017.03.023] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
65 Zhang J, Sun H, Salvi R, Ding D. Paraquat initially damages cochlear support cells leading to anoikis-like hair cell death. Hear Res 2018;364:129-41. [PMID: 29563067 DOI: 10.1016/j.heares.2018.03.014] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
66 Duracka M, Lukac N, Kacaniova M, Kantor A, Hleba L, Ondruska L, Tvrda E. Antibiotics Versus Natural Biomolecules: The Case of In Vitro Induced Bacteriospermia by Enterococcus Faecalis in Rabbit Semen. Molecules 2019;24:E4329. [PMID: 31783504 DOI: 10.3390/molecules24234329] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 5.0] [Reference Citation Analysis]
67 Sinan Başoğlu M, Eren E, Aslan H, Bingölballı AG, Öztürkcan S, Katılmış H. Prevention of cisplatin ototoxicity: Efficacy of micronized flavonoid fraction in a guinea pig model. International Journal of Pediatric Otorhinolaryngology 2012;76:1343-6. [DOI: 10.1016/j.ijporl.2012.06.003] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
68 Kamogashira T, Fujimoto C, Yamasoba T. Reactive oxygen species, apoptosis, and mitochondrial dysfunction in hearing loss. Biomed Res Int. 2015;2015:617207. [PMID: 25874222 DOI: 10.1155/2015/617207] [Cited by in Crossref: 76] [Cited by in F6Publishing: 59] [Article Influence: 12.7] [Reference Citation Analysis]
69 Üstün Bezgin S, Uygur KK, Gökdoğan Ç, Elmas Ç, Göktaş G. The Effects of Riluzole on Cisplatin-induced Ototoxicity. Int Arch Otorhinolaryngol 2019;23:e267-75. [PMID: 31360245 DOI: 10.1055/s-0038-1676654] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
70 Leyssens L, Vinck B, Van Der Straeten C, De Smet K, Dhooge I, Wuyts FL, Keppler H, Degeest S, Valette R, Lim R, Maes L. The Ototoxic Potential of Cobalt From Metal-on-Metal Hip Implants: Objective Auditory and Vestibular Outcome. Ear & Hearing 2020;41:217-30. [DOI: 10.1097/aud.0000000000000747] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
71 Peleva E, Emami N, Alzahrani M, Bezdjian A, Gurberg J, Carret AS, Daniel SJ. Incidence of platinum-induced ototoxicity in pediatric patients in Quebec. Pediatr Blood Cancer 2014;61:2012-7. [PMID: 24976616 DOI: 10.1002/pbc.25123] [Cited by in Crossref: 28] [Cited by in F6Publishing: 22] [Article Influence: 4.0] [Reference Citation Analysis]
72 Oldenburg J, Fosså SD, Ikdahl T. Genetic variants associated with cisplatin-induced ototoxicity. Pharmacogenomics 2008;9:1521-30. [PMID: 18855538 DOI: 10.2217/14622416.9.10.1521] [Cited by in Crossref: 19] [Cited by in F6Publishing: 14] [Article Influence: 1.6] [Reference Citation Analysis]
73 Du X, Li W, Gao X, West MB, Saltzman WM, Cheng CJ, Stewart C, Zheng J, Cheng W, Kopke RD. Regeneration of mammalian cochlear and vestibular hair cells through Hes1/Hes5 modulation with siRNA. Hear Res 2013;304:91-110. [PMID: 23850665 DOI: 10.1016/j.heares.2013.06.011] [Cited by in Crossref: 23] [Cited by in F6Publishing: 21] [Article Influence: 2.9] [Reference Citation Analysis]
74 Wang D, Shi S, Ren T, Zhang Y, Guo P, Wang J, Wang W. U0126 pretreatment inhibits cisplatin-induced apoptosis and autophagy in HEI-OC1 cells and cochlear hair cells. Toxicol Appl Pharmacol 2021;415:115447. [PMID: 33577918 DOI: 10.1016/j.taap.2021.115447] [Reference Citation Analysis]
75 Hemmativaghef E. Exposure to lead, mercury, styrene, and toluene and hearing impairment: evaluation of dose-response relationships, regulations, and controls. Journal of Occupational and Environmental Hygiene 2020;17:574-97. [DOI: 10.1080/15459624.2020.1842428] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
76 Teitz T, Fang J, Goktug AN, Bonga JD, Diao S, Hazlitt RA, Iconaru L, Morfouace M, Currier D, Zhou Y, Umans RA, Taylor MR, Cheng C, Min J, Freeman B, Peng J, Roussel MF, Kriwacki R, Guy RK, Chen T, Zuo J. CDK2 inhibitors as candidate therapeutics for cisplatin- and noise-induced hearing loss. J Exp Med 2018;215:1187-203. [PMID: 29514916 DOI: 10.1084/jem.20172246] [Cited by in Crossref: 32] [Cited by in F6Publishing: 25] [Article Influence: 10.7] [Reference Citation Analysis]
77 Chew TA, Zhang J, Feng L. High-Resolution Views and Transport Mechanisms of the NKCC1 and KCC Transporters. J Mol Biol 2021;433:167056. [PMID: 34022207 DOI: 10.1016/j.jmb.2021.167056] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
78 Shi X. Cochlear Vascular Pathology and Hearing Loss. In: Ramkumar V, Rybak LP, editors. Inflammatory Mechanisms in Mediating Hearing Loss. Cham: Springer International Publishing; 2018. pp. 61-90. [DOI: 10.1007/978-3-319-92507-3_4] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
79 Hucke A, Rinschen MM, Bauer OB, Sperling M, Karst U, Köppen C, Sommer K, Schröter R, Ceresa C, Chiorazzi A, Canta A, Semperboni S, Marmiroli P, Cavaletti G, Schlatt S, Schlatter E, Pavenstädt H, Heitplatz B, Van Marck V, Sparreboom A, Barz V, Knief A, Deuster D, Zehnhoff-Dinnesen AA, Ciarimboli G. An integrative approach to cisplatin chronic toxicities in mice reveals importance of organic cation-transporter-dependent protein networks for renoprotection. Arch Toxicol 2019;93:2835-48. [PMID: 31493026 DOI: 10.1007/s00204-019-02557-9] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 5.5] [Reference Citation Analysis]
80 Paken J, Govender CD, Pillay M, Sewram V. Cisplatin-Associated Ototoxicity: A Review for the Health Professional. J Toxicol 2016;2016:1809394. [PMID: 28115933 DOI: 10.1155/2016/1809394] [Cited by in Crossref: 53] [Cited by in F6Publishing: 41] [Article Influence: 10.6] [Reference Citation Analysis]
81 Op de Beeck K, Schacht J, Van Camp G. Apoptosis in acquired and genetic hearing impairment: the programmed death of the hair cell. Hear Res 2011;281:18-27. [PMID: 21782914 DOI: 10.1016/j.heares.2011.07.002] [Cited by in Crossref: 92] [Cited by in F6Publishing: 70] [Article Influence: 9.2] [Reference Citation Analysis]
82 Karasawa T, Steyger PS. An integrated view of cisplatin-induced nephrotoxicity and ototoxicity. Toxicol Lett 2015;237:219-27. [PMID: 26101797 DOI: 10.1016/j.toxlet.2015.06.012] [Cited by in Crossref: 221] [Cited by in F6Publishing: 190] [Article Influence: 36.8] [Reference Citation Analysis]
83 Todd DW, Philip RC, Niihori M, Ringle RA, Coyle KR, Zehri SF, Zabala L, Mudery JA, Francis RH, Rodriguez JJ, Jacob A. A Fully Automated High-Throughput Zebrafish Behavioral Ototoxicity Assay. Zebrafish 2017;14:331-42. [PMID: 28520533 DOI: 10.1089/zeb.2016.1412] [Cited by in Crossref: 13] [Cited by in F6Publishing: 6] [Article Influence: 3.3] [Reference Citation Analysis]
84 Lindsey AE, Townes-Anderson E. Antibiotics Reduce Retinal Cell Survival In Vitro. Neurotox Res 2018;33:781-9. [PMID: 29098663 DOI: 10.1007/s12640-017-9826-6] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
85 Campo P, Morata TC, Hong O. Chemical exposure and hearing loss. Dis Mon 2013;59:119-38. [PMID: 23507352 DOI: 10.1016/j.disamonth.2013.01.003] [Cited by in Crossref: 59] [Cited by in F6Publishing: 30] [Article Influence: 7.4] [Reference Citation Analysis]
86 Haase GM, Prasad KN, Cole WC, Baggett-strehlau JM, Wyatt SE. Antioxidant micronutrient impact on hearing disorders: concept, rationale, and evidence. American Journal of Otolaryngology 2011;32:55-61. [DOI: 10.1016/j.amjoto.2009.09.002] [Cited by in Crossref: 22] [Cited by in F6Publishing: 16] [Article Influence: 2.2] [Reference Citation Analysis]
87 Wilson C, Duckers J, Rajenderkumar D. Unusual discovery of a vestibular schwannoma following eradication therapy for Mycobacterium abscessus. BMJ Case Rep 2018;2018:bcr-2018-225572. [PMID: 30158267 DOI: 10.1136/bcr-2018-225572] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
88 Strenzke N, Pauli-magnus D, Meyer A, Brandt A, Maier H, Moser T. Update zur Physiologie und Pathophysiologie des Innenohrs: Pathomechanismen der sensorineuralen Schwerhörigkeit. HNO 2008;56:27-36. [DOI: 10.1007/s00106-007-1640-7] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
89 Choi MJ, Kang H, Lee YY, Choo OS, Jang JH, Park SH, Moon JS, Choi SJ, Choung YH. Cisplatin-Induced Ototoxicity in Rats Is Driven by RIP3-Dependent Necroptosis. Cells 2019;8:E409. [PMID: 31052605 DOI: 10.3390/cells8050409] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 8.0] [Reference Citation Analysis]
90 Tserga E, Nandwani T, Edvall NK, Bulla J, Patel P, Canlon B, Cederroth CR, Baguley DM. The genetic vulnerability to cisplatin ototoxicity: a systematic review. Sci Rep 2019;9:3455. [PMID: 30837596 DOI: 10.1038/s41598-019-40138-z] [Cited by in Crossref: 21] [Cited by in F6Publishing: 11] [Article Influence: 10.5] [Reference Citation Analysis]
91 Yu X, Fan Z, Han Y, Zhang D, Xu L, Wang M, Yang Q, Li H, Zhou M, Zhang L, Sun G, Bai X, Li J, Wang H. Paeoniflorin reduces neomycin-induced ototoxicity in hair cells by suppression of reactive oxygen species generation and extracellularly regulated kinase signalization. Toxicol Lett 2018;285:9-19. [PMID: 29292089 DOI: 10.1016/j.toxlet.2017.12.026] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
92 Vlajkovic SM, Housley GD, Thorne PR. Adenosine and the auditory system. Curr Neuropharmacol. 2009;7:246-256. [PMID: 20190966 DOI: 10.2174/157015909789152155] [Cited by in Crossref: 35] [Cited by in F6Publishing: 33] [Article Influence: 3.2] [Reference Citation Analysis]
93 Martín-Saldaña S, Palao-Suay R, Aguilar MR, Ramírez-Camacho R, San Román J. Polymeric nanoparticles loaded with dexamethasone or α-tocopheryl succinate to prevent cisplatin-induced ototoxicity. Acta Biomater 2017;53:199-210. [PMID: 28213099 DOI: 10.1016/j.actbio.2017.02.019] [Cited by in Crossref: 28] [Cited by in F6Publishing: 25] [Article Influence: 7.0] [Reference Citation Analysis]
94 Gunewardene N. Adenosine amine congener ameliorates cisplatin-induced hearing loss. WJO 2013;3:100. [DOI: 10.5319/wjo.v3.i3.100] [Cited by in CrossRef: 8] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
95 Mahomed W, Heinze BM, Vinck BH, Stoltz A. Auditory, video head impulse test and vestibular evoked myogenic potentials findings in adults with human immunodeficiency virus. Auris Nasus Larynx 2020;47:367-76. [PMID: 31862282 DOI: 10.1016/j.anl.2019.11.006] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
96 Kelles M, Tan M, Kalcioglu MT, Toplu Y, Bulam N. The Protective Effect of Chrysin Against Cisplatin İnduced Ototoxicity in Rats. Indian J Otolaryngol Head Neck Surg 2014;66:369-74. [PMID: 26396946 DOI: 10.1007/s12070-013-0695-x] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
97 Campbell KCM, Le Prell CG. Drug-Induced Ototoxicity: Diagnosis and Monitoring. Drug Saf 2018;41:451-64. [PMID: 29404977 DOI: 10.1007/s40264-017-0629-8] [Cited by in Crossref: 21] [Cited by in F6Publishing: 17] [Article Influence: 7.0] [Reference Citation Analysis]
98 Paken J, Govender CD, Pillay M, Ayele BT, Sewram V. Feasibility and first results of a prospective cohort study to investigate cisplatin-associated ototoxicity amongst cancer patients in South Africa. BMC Cancer 2021;21:822. [PMID: 34271863 DOI: 10.1186/s12885-021-08567-0] [Reference Citation Analysis]
99 Harrach S, Ciarimboli G. Role of transporters in the distribution of platinum-based drugs. Front Pharmacol 2015;6:85. [PMID: 25964760 DOI: 10.3389/fphar.2015.00085] [Cited by in Crossref: 47] [Cited by in F6Publishing: 39] [Article Influence: 7.8] [Reference Citation Analysis]
100 Niihori M, Platto T, Igarashi S, Hurbon A, Dunn AM, Tran P, Tran H, Mudery JA, Slepian MJ, Jacob A. Zebrafish swimming behavior as a biomarker for ototoxicity-induced hair cell damage: a high-throughput drug development platform targeting hearing loss. Translational Research 2015;166:440-50. [DOI: 10.1016/j.trsl.2015.05.002] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 3.2] [Reference Citation Analysis]
101 Prakash Krishnan Muthaiah V, Ding D, Salvi R, Roth JA. Carbaryl-induced ototoxicity in rat postnatal cochlear organotypic cultures. Environ Toxicol 2017;32:956-69. [PMID: 27296064 DOI: 10.1002/tox.22296] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.4] [Reference Citation Analysis]
102 Esterberg R, Coffin AB, Ou H, Simon JA, Raible DW, Rubel EW. Fish in a Dish: Drug Discovery for Hearing Habilitation. Drug Discov Today Dis Models 2013;10. [PMID: 24187569 DOI: 10.1016/j.ddmod.2012.02.001] [Cited by in Crossref: 34] [Cited by in F6Publishing: 35] [Article Influence: 4.3] [Reference Citation Analysis]
103 Kushner B, Allen PD, Crane BT. Frequency and Demographics of Gentamicin Use. Otol Neurotol 2016;37:190-5. [PMID: 26719956 DOI: 10.1097/MAO.0000000000000937] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 1.6] [Reference Citation Analysis]
104 Wong AC, Guo CX, Gupta R, Housley GD, Thorne PR, Vlajkovic SM. Post exposure administration of A(1) adenosine receptor agonists attenuates noise-induced hearing loss. Hear Res. 2010;260:81-88. [PMID: 19995597 DOI: 10.1016/j.heares.2009.12.004] [Cited by in Crossref: 30] [Cited by in F6Publishing: 30] [Article Influence: 2.5] [Reference Citation Analysis]
105 Takimoto Y, Imai T, Kondo M, Hanada Y, Uno A, Ishida Y, Kamakura T, Kitahara T, Inohara H, Shimada S. Cisplatin-induced toxicity decreases the mouse vestibulo-ocular reflex. Toxicol Lett 2016;262:49-54. [PMID: 27659732 DOI: 10.1016/j.toxlet.2016.09.009] [Cited by in Crossref: 14] [Cited by in F6Publishing: 10] [Article Influence: 2.8] [Reference Citation Analysis]
106 Kang AD, Smith KP, Eliopoulos GM, Berg AH, McCoy C, Kirby JE. Invitro Apramycin Activity against multidrug-resistant Acinetobacter baumannii and Pseudomonas aeruginosa. Diagn Microbiol Infect Dis 2017;88:188-91. [PMID: 28341099 DOI: 10.1016/j.diagmicrobio.2017.03.006] [Cited by in Crossref: 33] [Cited by in F6Publishing: 28] [Article Influence: 8.3] [Reference Citation Analysis]
107 Tang Q, Wang X, Jin H, Mi Y, Liu L, Dong M, Chen Y, Zou Z. Cisplatin-induced ototoxicity: Updates on molecular mechanisms and otoprotective strategies. Eur J Pharm Biopharm 2021;163:60-71. [PMID: 33775853 DOI: 10.1016/j.ejpb.2021.03.008] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
108 Boyle KL, Rosenbaum CD. Oxymorphone insufflation associated with acute sensorineural hearing loss: case files of the University of Massachusetts medical toxicology fellowship. J Med Toxicol 2013;9:179-83. [PMID: 23435934 DOI: 10.1007/s13181-013-0293-z] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
109 Barros TP, Alderton WK, Reynolds HM, Roach AG, Berghmans S. Zebrafish: an emerging technology for in vivo pharmacological assessment to identify potential safety liabilities in early drug discovery. Br J Pharmacol 2008;154:1400-13. [PMID: 18552866 DOI: 10.1038/bjp.2008.249] [Cited by in Crossref: 195] [Cited by in F6Publishing: 157] [Article Influence: 15.0] [Reference Citation Analysis]
110 Bovo R, Ciorba A, Martini A. Environmental and genetic factors in age-related hearing impairment. Aging Clin Exp Res 2011;23:3-10. [PMID: 21499014 DOI: 10.1007/BF03324947] [Cited by in Crossref: 36] [Cited by in F6Publishing: 13] [Article Influence: 3.6] [Reference Citation Analysis]
111 Ding D, Roth J, Salvi R. Manganese is toxic to spiral ganglion neurons and hair cells in vitro. Neurotoxicology 2011;32:233-41. [PMID: 21182863 DOI: 10.1016/j.neuro.2010.12.003] [Cited by in Crossref: 47] [Cited by in F6Publishing: 42] [Article Influence: 4.3] [Reference Citation Analysis]
112 Tropitzsch A, Arnold H, Bassiouni M, Müller A, Eckhard A, Müller M, Löwenheim H. Assessing cisplatin-induced ototoxicity and otoprotection in whole organ culture of the mouse inner ear in simulated microgravity. Toxicol Lett 2014;227:203-12. [PMID: 24709139 DOI: 10.1016/j.toxlet.2014.03.022] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 1.6] [Reference Citation Analysis]
113 Wu J, Ye J, Kong W, Zhang S, Zheng Y. Programmed cell death pathways in hearing loss: A review of apoptosis, autophagy and programmed necrosis. Cell Prolif 2020;53:e12915. [PMID: 33047870 DOI: 10.1111/cpr.12915] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
114 Philip RC, Rodriguez JJ, Niihori M, Francis RH, Mudery JA, Caskey JS, Krupinski E, Jacob A. Automated High-Throughput Damage Scoring of Zebrafish Lateral Line Hair Cells After Ototoxin Exposure. Zebrafish 2018;15:145-55. [PMID: 29381431 DOI: 10.1089/zeb.2017.1451] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.7] [Reference Citation Analysis]
115 Zou J, Li M, Zhang Y, Zheng G, Chen D, Chen S, Zheng H. Transport augmentation through the blood-inner ear barriers of guinea pigs treated with 3-nitropropionic acid and patients with acute hearing loss, visualized with 3.0 T MRI. Otol Neurotol 2011;32:204-12. [PMID: 21150687 DOI: 10.1097/MAO.0b013e3182016332] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
116 Ojano-dirain CP, Antonelli PJ. Prevention of gentamicin-induced apoptosis with the mitochondria-targeted antioxidant mitoquinone. The Laryngoscope 2012;122:2543-8. [DOI: 10.1002/lary.23593] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 1.8] [Reference Citation Analysis]
117 Cakil B, Basar FS, Atmaca S, Cengel SK, Tekat A, Tanyeri Y. The protective effect of Ginkgo biloba extract against experimental cisplatin ototoxicity: animal research using distortion product otoacoustic emissions. J Laryngol Otol 2012;126:1097-101. [PMID: 22975015 DOI: 10.1017/S0022215112002046] [Cited by in Crossref: 11] [Cited by in F6Publishing: 2] [Article Influence: 1.2] [Reference Citation Analysis]
118 Choung YH, Kim SW, Tian C, Min JY, Lee HK, Park SN, Lee JB, Park K. Korean red ginseng prevents gentamicin-induced hearing loss in rats. Laryngoscope 2011;121:1294-302. [PMID: 21541943 DOI: 10.1002/lary.21756] [Cited by in Crossref: 26] [Cited by in F6Publishing: 21] [Article Influence: 2.6] [Reference Citation Analysis]
119 Wang T, Yang YQ, Karasawa T, Wang Q, Phillips A, Guan BC, Ma KT, Jiang M, Xie DH, Steyger PS, Jiang ZG. Bumetanide hyperpolarizes madin-darby canine kidney cells and enhances cellular gentamicin uptake by elevating cytosolic Ca(2+) thus facilitating intermediate conductance Ca(2+)--activated potassium channels. Cell Biochem Biophys 2013;65:381-98. [PMID: 23109177 DOI: 10.1007/s12013-012-9442-2] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
120 Somdaş MA, Güntürk İ, Balcıoğlu E, Avcı D, Yazıcı C, Özdamar S. Protective effect of N-acetylcysteine against cisplatin ototoxicity in rats: a study with hearing tests and scanning electron microscopy. Braz J Otorhinolaryngol 2020;86:30-7. [PMID: 30268784 DOI: 10.1016/j.bjorl.2018.08.002] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
121 Waissbluth S, Salehi P, He X, Daniel SJ. Systemic dexamethasone for the prevention of cisplatin-induced ototoxicity. Eur Arch Otorhinolaryngol 2013;270:1597-605. [DOI: 10.1007/s00405-012-2150-0] [Cited by in Crossref: 24] [Cited by in F6Publishing: 21] [Article Influence: 2.7] [Reference Citation Analysis]
122 Dobrzyńska I, Skrzydlewska E, Figaszewski ZA. Effects of Novel Dinuclear Cisplatinum(II) Complexes on the Electrical Properties of Human Molt-4 Leukemia Cells. Cell Biochem Biophys 2015;71:1517-23. [PMID: 25399303 DOI: 10.1007/s12013-014-0375-9] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
123 Xu F, Yan W, Cheng Y. Pou4f3 gene mutation promotes autophagy and apoptosis of cochlear hair cells in cisplatin-induced deafness mice. Arch Biochem Biophys 2020;680:108224. [PMID: 31830441 DOI: 10.1016/j.abb.2019.108224] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
124 Chandrika NT, Garneau-Tsodikova S. A review of patents (2011-2015) towards combating resistance to and toxicity of aminoglycosides. Medchemcomm 2016;7:50-68. [PMID: 27019689 DOI: 10.1039/C5MD00453E] [Cited by in Crossref: 36] [Cited by in F6Publishing: 12] [Article Influence: 6.0] [Reference Citation Analysis]
125 Zhou Y, Ding D, Kraus KS, Yu D, Salvi RJ. Functional and structural changes in the chinchilla cochlea and vestibular system following round window application of carboplatin. Audiol Med 2009;7:189-99. [PMID: 20046821 DOI: 10.3109/16513860903335795] [Cited by in Crossref: 16] [Cited by in F6Publishing: 11] [Article Influence: 1.3] [Reference Citation Analysis]
126 Moon IS, So JH, Jung YM, Lee WS, Kim EY, Choi JH, Kim CH, Choi JY. Fucoidan promotes mechanosensory hair cell regeneration following amino glycoside-induced cell death. Hear Res 2011;282:236-42. [PMID: 21810458 DOI: 10.1016/j.heares.2011.07.007] [Cited by in Crossref: 20] [Cited by in F6Publishing: 14] [Article Influence: 2.0] [Reference Citation Analysis]
127 Fernandez K, Wafa T, Fitzgerald TS, Cunningham LL. An optimized, clinically relevant mouse model of cisplatin-induced ototoxicity. Hear Res 2019;375:66-74. [PMID: 30827780 DOI: 10.1016/j.heares.2019.02.006] [Cited by in Crossref: 17] [Cited by in F6Publishing: 12] [Article Influence: 8.5] [Reference Citation Analysis]
128 Van Hecke R, Van Rompaey V, Wuyts FL, Leyssens L, Maes L. Systemic Aminoglycosides-Induced Vestibulotoxicity in Humans. Ear & Hearing 2017;38:653-62. [DOI: 10.1097/aud.0000000000000458] [Cited by in Crossref: 15] [Cited by in F6Publishing: 4] [Article Influence: 3.8] [Reference Citation Analysis]
129 Paken J, Govender CD, Pillay M, Sewram V. A Review of Cisplatin-Associated Ototoxicity. Semin Hear 2019;40:108-21. [PMID: 31036989 DOI: 10.1055/s-0039-1684041] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 6.5] [Reference Citation Analysis]
130 Li M, Zhang Y, Qiu S, Zhuang W, Jiang W, Wang C, Zhang S, Zhou Z, Sun T, Ke Z, Guo W, Qiao Y, Shi X. Oridonin ameliorates noise-induced hearing loss by blocking NLRP3 - NEK7 mediated inflammasome activation. Int Immunopharmacol 2021;95:107576. [PMID: 33770730 DOI: 10.1016/j.intimp.2021.107576] [Reference Citation Analysis]
131 Smith KP, Kirby JE. Evaluation of apramycin activity against carbapenem-resistant and -susceptible strains of Enterobacteriaceae. Diagn Microbiol Infect Dis 2016;86:439-41. [PMID: 27745736 DOI: 10.1016/j.diagmicrobio.2016.09.002] [Cited by in Crossref: 28] [Cited by in F6Publishing: 26] [Article Influence: 5.6] [Reference Citation Analysis]
132 Joo Y, Cruickshanks KJ, Klein BEK, Klein R, Hong O, Wallhagen MI. The Contribution of Ototoxic Medications to Hearing Loss Among Older Adults. J Gerontol A Biol Sci Med Sci 2020;75:561-6. [PMID: 31282945 DOI: 10.1093/gerona/glz166] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 6.0] [Reference Citation Analysis]
133 Kınal ME, Tatlıpınar A, Uzun S, Keskin S, Tekdemir E, Özbeyli D, Akakın D. Investigation of Astaxanthin Effect on Cisplatin Ototoxicity in Rats by Using Otoacoustic Emission, Total Antioxidant Capacity, and Histopathological Methods. Ear Nose Throat J 2021;100:NP198-205. [PMID: 31558064 DOI: 10.1177/0145561319866826] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
134 Buck LM, Winter MJ, Redfern WS, Whitfield TT. Ototoxin-induced cellular damage in neuromasts disrupts lateral line function in larval zebrafish. Hearing Research 2012;284:67-81. [DOI: 10.1016/j.heares.2011.12.001] [Cited by in Crossref: 57] [Cited by in F6Publishing: 44] [Article Influence: 6.3] [Reference Citation Analysis]
135 Stawicki TM, Owens KN, Linbo T, Reinhart KE, Rubel EW, Raible DW. The zebrafish merovingian mutant reveals a role for pH regulation in hair cell toxicity and function. Dis Model Mech 2014;7:847-56. [PMID: 24973752 DOI: 10.1242/dmm.016576] [Cited by in Crossref: 30] [Cited by in F6Publishing: 21] [Article Influence: 5.0] [Reference Citation Analysis]
136 Blakley BW, Alsaleh S, Dewji Z, Qureshy K, Berard S, Xie L. Steroids in aminoglycoside-containing ear drops: do they reduce cochlear toxicity? Laryngoscope 2014;124:1209-13. [PMID: 24142776 DOI: 10.1002/lary.24475] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
137 Kent A, Turner MA, Sharland M, Heath PT. Aminoglycoside toxicity in neonates: something to worry about? Expert Rev Anti Infect Ther 2014;12:319-31. [PMID: 24455994 DOI: 10.1586/14787210.2014.878648] [Cited by in Crossref: 41] [Cited by in F6Publishing: 27] [Article Influence: 5.9] [Reference Citation Analysis]
138 Uzun L, Kokten N, Cam OH, Kalcioglu MT, Ugur MB, Tekin M, Acar GO. The Effect of Garlic Derivatives (S-Allylmercaptocysteine, Diallyl Disulfide, and S-Allylcysteine) on Gentamicin Induced Ototoxicity: An Experimental Study. Clin Exp Otorhinolaryngol 2016;9:309-13. [PMID: 27136366 DOI: 10.21053/ceo.2015.01032] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 1.6] [Reference Citation Analysis]
139 Hucke A, Ciarimboli G. The Role of Transporters in the Toxicity of Chemotherapeutic Drugs: Focus on Transporters for Organic Cations. J Clin Pharmacol 2016;56 Suppl 7:S157-72. [PMID: 27385173 DOI: 10.1002/jcph.706] [Cited by in Crossref: 22] [Cited by in F6Publishing: 18] [Article Influence: 5.5] [Reference Citation Analysis]
140 Heinrich UR, Strieth S, Schmidtmann I, Li H, Helling K. Gentamicin alters Akt-expression and its activation in the guinea pig cochlea. Neuroscience 2015;311:490-8. [PMID: 26528886 DOI: 10.1016/j.neuroscience.2015.10.050] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
141 Lykke K, Töllner K, Römermann K, Feit PW, Erker T, MacAulay N, Löscher W. Structure-activity relationships of bumetanide derivatives: correlation between diuretic activity in dogs and inhibition of the human NKCC2A transporter. Br J Pharmacol 2015;172:4469-80. [PMID: 26101812 DOI: 10.1111/bph.13231] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 1.8] [Reference Citation Analysis]
142 Dogan M, Sahin M, Cetin N, Yilmaz M, Demirci B. Utilizing prestin as a predictive marker for the early detection of outer hair cell damage. American Journal of Otolaryngology 2018;39:594-8. [DOI: 10.1016/j.amjoto.2018.07.007] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
143 Sagit M, Korkmaz F, Gürgen SG, Kaya M, Akcadag A, Ozcan I. The protective role of thymoquinone in the prevention of gentamicin ototoxicity. American Journal of Otolaryngology 2014;35:603-9. [DOI: 10.1016/j.amjoto.2014.07.002] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 1.4] [Reference Citation Analysis]
144 Mukherjea D, Jajoo S, Sheehan K, Kaur T, Sheth S, Bunch J, Perro C, Rybak LP, Ramkumar V. NOX3 NADPH oxidase couples transient receptor potential vanilloid 1 to signal transducer and activator of transcription 1-mediated inflammation and hearing loss. Antioxid Redox Signal 2011;14:999-1010. [PMID: 20712533 DOI: 10.1089/ars.2010.3497] [Cited by in Crossref: 54] [Cited by in F6Publishing: 49] [Article Influence: 4.9] [Reference Citation Analysis]
145 Wang D, Shi S, Hsieh YL, Wang J, Wang H, Wang W. Knockdown of sorcin increases HEI-OC1 cell damage induced by cisplatin in vitro. Arch Biochem Biophys 2021;701:108752. [PMID: 33675811 DOI: 10.1016/j.abb.2021.108752] [Reference Citation Analysis]
146 Graydon K, Waterworth C, Miller H, Gunasekera H. Global burden of hearing impairment and ear disease. J Laryngol Otol 2019;133:18-25. [DOI: 10.1017/s0022215118001275] [Cited by in Crossref: 43] [Cited by in F6Publishing: 18] [Article Influence: 14.3] [Reference Citation Analysis]
147 Ruhl D, Du TT, Wagner EL, Choi JH, Li S, Reed R, Kim K, Freeman M, Hashisaki G, Lukens JR, Shin JB. Necroptosis and Apoptosis Contribute to Cisplatin and Aminoglycoside Ototoxicity. J Neurosci 2019;39:2951-64. [PMID: 30733218 DOI: 10.1523/JNEUROSCI.1384-18.2019] [Cited by in Crossref: 18] [Cited by in F6Publishing: 10] [Article Influence: 9.0] [Reference Citation Analysis]
148 Sagit M, Korkmaz F, Gürgen SG, Gundogdu R, Akcadag A, Ozcan I. Quercetine attenuates the gentamicin-induced ototoxicity in a rat model. Int J Pediatr Otorhinolaryngol 2015;79:2109-14. [PMID: 26434546 DOI: 10.1016/j.ijporl.2015.09.023] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
149 Jadidian A, Antonelli PJ, Ojano-Dirain CP. Evaluation of apoptotic markers in HEI-OC1 cells treated with gentamicin with and without the mitochondria-targeted antioxidant mitoquinone. Otol Neurotol 2015;36:526-30. [PMID: 25076226 DOI: 10.1097/MAO.0000000000000517] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.2] [Reference Citation Analysis]
150 Yu L, Jiang XH, Zhou Z, Tsang LL, Yu MK, Chung YW, Zhang XH, Wang AM, Tang H, Chan HC. A protective mechanism against antibiotic-induced ototoxicity: role of prestin. PLoS One 2011;6:e17322. [PMID: 21364896 DOI: 10.1371/journal.pone.0017322] [Cited by in Crossref: 16] [Cited by in F6Publishing: 12] [Article Influence: 1.6] [Reference Citation Analysis]
151 Ozkul Y, Songu M, Basoglu MS, Ozturkcan S, Katilmis H. Evaluation of the Protective Effect of α-Lipoic Acid on Cisplatin Ototoxicity Using Distortion-Product Otoacoustic Emission Measurements: An Experimental Animal Study. Journal of Craniofacial Surgery 2014;25:1515-8. [DOI: 10.1097/scs.0000000000000881] [Cited by in Crossref: 6] [Cited by in F6Publishing: 1] [Article Influence: 0.9] [Reference Citation Analysis]
152 Kim SH, Jung G, Kim S, Koo JW. Novel Peptide Vaccine GV1001 Rescues Hearing in Kanamycin/Furosemide-Treated Mice. Front Cell Neurosci 2018;12:3. [PMID: 29403358 DOI: 10.3389/fncel.2018.00003] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
153 Alharazneh A, Luk L, Huth M, Monfared A, Steyger PS, Cheng AG, Ricci AJ. Functional hair cell mechanotransducer channels are required for aminoglycoside ototoxicity. PLoS One 2011;6:e22347. [PMID: 21818312 DOI: 10.1371/journal.pone.0022347] [Cited by in Crossref: 148] [Cited by in F6Publishing: 129] [Article Influence: 14.8] [Reference Citation Analysis]
154 Nan B, Gu X, Huang X. The Role of the Reactive Oxygen Species Scavenger Agent, Astaxanthin, in the Protection of Cisplatin-Treated Patients Against Hearing Loss. Drug Des Devel Ther 2019;13:4291-303. [PMID: 31908415 DOI: 10.2147/DDDT.S212313] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
155 Gündoğdu R, Erkan M, Aydın M, Sönmez MF, Vural A, Kökoğlu K, Karabulut D, Şahin Mİ. Assessment of the Effectiveness of Quercetin on Cisplatin-Induced Ototoxicity in Rats. J Int Adv Otol 2019;15:229-36. [PMID: 31287434 DOI: 10.5152/iao.2019.5902] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
156 Smedowski A, Pietrucha-Dutczak M, Maniar R, Ajeleti M, Matuszek I, Lewin-Kowalik J. FluoroGold-Labeled Organotypic Retinal Explant Culture for Neurotoxicity Screening Studies. Oxid Med Cell Longev 2018;2018:2487473. [PMID: 29560079 DOI: 10.1155/2018/2487473] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 2.3] [Reference Citation Analysis]
157 Swan EE, Mescher MJ, Sewell WF, Tao SL, Borenstein JT. Inner ear drug delivery for auditory applications. Adv Drug Deliv Rev. 2008;60:1583-1599. [PMID: 18848590 DOI: 10.1016/j.addr.2008.08.001] [Cited by in Crossref: 120] [Cited by in F6Publishing: 94] [Article Influence: 9.2] [Reference Citation Analysis]